MedTrace Logo

Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment

NCT04435769 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2023-02-08

Study results available
· View outcomes & findings →

Summary

To describe the direct costs related to warfarin/apixaban treatment

Conditions

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-04
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04435769 on ClinicalTrials.gov